An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type ...

Texas has one of the highest rates of diabetes in the country, with more than 2.7 million Texans diagnosed with the condition. About one in six people in San Antonio have type 2 diabetes, and a third ...

Bayer's big investment in time and money on the development of finerenone for chronic kidney disease (CKD ... other countries for patients with CKD and type 2 diabetes. Bayer meanwhile is also ...

Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD ... impact on COPD outcomes in patients with type 2 diabetes.” ...

Bayer has launched a digital patient support package in England designed to help people with type 2 diabetes look after the health of their kidneys and avoid progression to chronic kidney disease ...

Yo-Yo Dieting May Significantly Increase Kidney Disease Risk in People ... Jan. 29, 2025 — A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a ...

Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an increased risk for renal events.

At the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...